Galmed Pharmaceuticals Ltd (GLMD) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Galmed Pharmaceuticals Ltd   (NASDAQ: GLMD)


Galmed Pharmaceuticals Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Galmed Pharmaceuticals Ltd's ROI in the fourth quarter of 2025?
Galmed Pharmaceuticals Ltd recorded a cumulative net loss of $-4 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -22.63%.

Within the Healthcare sector 28 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 85 to 97.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 21.89 % 28.12 % 37.99 % 24.21 % 17.91 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 16 19 21 17 16
Return On Investment (TTM) -22.63 % -12.58 % -12.82 % -5.91 % -7.47 %
GLMD's Overall Ranking # 97 # 85 # # #
Seq. Investment Change TTM -0.75 % 0.94 % 13.77 % 6.95 % 4.32 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -4 -2 -2 -1 -1

GLMD Company Profile >> Back to GLMD Roi Comparisons >> See Annual GLMD Return On Investment



Return On Investment GLMD's Ranking
Within: No.
Industry # 10
Sector # 29
Overall # 97

Return On Investment Statistics
High Average Low
133.1 %
54.29 %
5.1 %
(Dec 31 2022)   (Jun 30 2018)







Financial Statements
Galmed Pharmaceuticals Ltd's IV. Quarter Investments $ 16 Millions GLMD's Balance sheet
Galmed Pharmaceuticals Ltd's IV. Quarter Income $ 1 Millions Quarterly GLMD's Income Statement
GLMD's Income by Division See GLMD's Income by Division


GLMD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 16 16 14 13 30
Y / Y Investment Growth -3.36 % 17.68 % 3.34 % -55.96 % -30.93 %
Net Income in Millions 7 8 10 18 32
Y / Y Net Income Growth -8 % -27.18 % -42.46 % -44.75 % -
Annual Return On Investment 43.72 % 45.92 % 74.21 % 133.28 % 106.24 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 43.72 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GLMD's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GLMD's Competitors
Subscribers only: Roi for Galmed Pharmaceuticals Ltd's Suppliers
Subscribers only: Return On Investment for GLMD's Customers

Other Ratios
GLMD's Roa GLMD's Inventory Turnover Ratio GLMD's Growth Rates GLMD's Dividend Statistics
GLMD's Profitability Ratios GLMD's Asset Turnover Ratio GLMD's Dividend Growth
GLMD's Roe GLMD's Valuation Ratios GLMD's Financial Strength Ratios GLMD's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-08-29T01:15:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.